GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revolution Medicines Inc (FRA:42Z) » Definitions » Sale Of Investment

Revolution Medicines (FRA:42Z) Sale Of Investment : €1,473.53 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Revolution Medicines Sale Of Investment?

Revolution Medicines's sale of investment for the three months ended in Dec. 2024 was €289.87 Mil. It means Revolution Medicines gained €289.87 Mil from selling investments. Revolution Medicines's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €1,473.53 Mil.

Compared with last quarter (€312.58 Mil in Sep. 2024 ), Revolution Medicines gained less money from selling investments in Dec. 2024 (€289.87 Mil).


Revolution Medicines Sale Of Investment Historical Data

The historical data trend for Revolution Medicines's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revolution Medicines Sale Of Investment Chart

Revolution Medicines Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial 257.15 474.14 565.90 663.95 1,520.87

Revolution Medicines Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 129.77 420.33 450.75 312.58 289.87

Revolution Medicines Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,473.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revolution Medicines Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Revolution Medicines's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Revolution Medicines Business Description

Traded in Other Exchanges
Address
700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Revolution Medicines Headlines

No Headlines